Join
Live feed
·
INSIDERFilingvia Quantisnow
Genocea Biosciences Inc. logo

SEC Form 4: Duvall Diantha sold $81 worth of shares (1,355 units at $0.06), decreasing direct ownership by 2% to 75,388 units to satisfy tax liability

ByQuantisnow·Wall Street's wire, on your screen.
GNCA· Genocea Biosciences Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track GNCA (Genocea Biosciences Inc.) and more on Quantisnow.

SEC Form 4: Duvall Diantha sold $81 worth of shares (1,355 units at $0.06), decreasing direct ownership by 2% to 75,388 units to satisfy tax liability | Quantisnow